Mr. Walton spoke at MDMA’s annual meeting in late May and discussed his experiences as a patient undergoing spinal fusion surgery and the challenges the industry faces, including the medical device excise tax, regulatory struggles with the FDA and reimbursement with CMS. After his speech, Mr. Walton and NuVasive CEO Alex Lukianov traveled to Capitol Hill to lobby lawmakers on these issues.
Related Articles on Medical Devices:
Smith & Nephew Voluntarily Withdraws Hip System Component
